v3.25.2
Segment Reporting
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting

Note 15 – Segment Reporting

The Company is organized under two reportable segments: Automotive and Medical.

The Automotive reporting segment is comprised of the results from our global automotive businesses, including the design, development, manufacturing and sales of our automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products.

The Medical reporting segment is comprised of the results from our patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.

The Corporate and other unallocated expenses category includes certain enterprise and governance activities resulting in unallocated corporate costs and other activity and net costs that the Company may choose not to allocate directly to its business segments.

A measure of assets has not been disclosed for each segment as it is not regularly reviewed by our chief operating decision maker.

The table below presents segment information about the reported product revenues, significant segment expenses, operating income (loss) and depreciation and amortization of the Company for the three and six months ended June 30, 2025 and 2024.

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Product Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

363,852

 

 

$

364,002

 

 

$

705,726

 

 

$

708,640

 

Medical

 

 

11,238

 

 

 

11,681

 

 

 

23,218

 

 

 

23,058

 

Total

 

 

375,090

 

 

 

375,683

 

 

 

728,944

 

 

 

731,698

 

 

 

 

 

 

 

 

 

 

 

 

 

Significant Segment Expenses and Operating Performance

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

278,424

 

 

 

272,093

 

 

 

538,651

 

 

 

532,382

 

Net research and development expenses

 

 

17,818

 

 

 

17,012

 

 

 

37,202

 

 

 

34,436

 

Selling, general and administrative expenses

 

 

16,814

 

 

 

17,037

 

 

 

32,533

 

 

 

33,638

 

Restructuring expenses, net

 

 

1,924

 

 

 

1,694

 

 

 

6,438

 

 

 

8,808

 

Loss on sale of land and building, net

 

 

 

 

 

 

 

 

2,196

 

 

 

 

Automotive operating income

 

 

48,872

 

 

 

56,166

 

 

 

88,706

 

 

 

99,376

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

5,729

 

 

 

6,101

 

 

 

12,005

 

 

 

12,014

 

Other operating expenses

 

 

5,846

 

 

 

5,302

 

 

 

11,155

 

 

 

10,719

 

Impairment of intangible assets

 

 

 

 

 

 

 

 

 

 

 

530

 

Medical operating (loss) income

 

 

(337

)

 

 

278

 

 

 

58

 

 

 

(205

)

 

 

 

 

 

 

 

 

 

 

 

 

Corporate and Other Unallocated Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Corporate and other unallocated expenses

 

 

24,526

 

 

 

23,456

 

 

 

47,694

 

 

 

48,134

 

Total consolidated operating income

 

$

24,009

 

 

$

32,988

 

 

$

41,070

 

 

$

51,037

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Segment Disclosures

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

11,796

 

 

$

11,817

 

 

$

23,398

 

 

$

24,225

 

Medical

 

 

851

 

 

 

869

 

 

 

1,706

 

 

 

1,752

 

Corporate and other unallocated expenses

 

 

511

 

 

 

229

 

 

 

985

 

 

 

756

 

Total

 

$

13,158

 

 

$

12,915

 

 

$

26,089

 

 

$

26,733

 

 

Automotive and Medical segment product revenues by product category for the three and six months ended June 30, 2025 and 2024 were as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Climate Control Seats (a)

 

$

200,020

 

 

$

199,766

 

 

$

391,173

 

 

$

391,815

 

Lumbar and Massage Comfort Solutions

 

 

52,530

 

 

 

45,869

 

 

 

97,843

 

 

 

84,120

 

Climate Control Interiors (a)

 

 

49,585

 

 

 

47,031

 

 

 

94,926

 

 

 

91,429

 

Climate and Comfort Electronics (a)

 

 

5,906

 

 

 

4,157

 

 

 

13,621

 

 

 

8,383

 

Automotive Climate and Comfort Solutions

 

 

308,041

 

 

 

296,823

 

 

 

597,563

 

 

 

575,747

 

Valve Systems

 

 

25,143

 

 

 

29,267

 

 

 

48,316

 

 

 

55,892

 

Other Automotive (a)

 

 

30,668

 

 

 

37,912

 

 

 

59,847

 

 

 

77,001

 

Subtotal Automotive segment

 

 

363,852

 

 

 

364,002

 

 

 

705,726

 

 

 

708,640

 

Medical segment

 

 

11,238

 

 

 

11,681

 

 

 

23,218

 

 

 

23,058

 

Total Company

 

$

375,090

 

 

$

375,683

 

 

$

728,944

 

 

$

731,698

 

(a)
Product categories have been modified, and prior-period amounts have been recast to conform with the current period presentation. Climate Control Seats (CCS) includes CCS Heat (previously Seat Heaters), CCS Vent/CCS Active Cool (previously CCS) and CCS Neck Conditioners (previously included in Other Automotive). Climate Control Interiors (CCI) includes CCI Steering Wheel Heat and CCI Interior Heat (previously included in Other Automotive). Other Automotive includes Automotive Cables, Battery Performance Solutions, non-automotive electronics and contract manufacturing electronics (previously classified as Electronics).

Revenue (based on shipment destination) by geographic area for the three and six months ended June 30, 2025 and 2024 is as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

United States

 

$

126,745

 

 

$

127,359

 

 

$

251,671

 

 

$

252,812

 

China

 

 

54,600

 

 

 

53,209

 

 

 

103,535

 

 

 

107,685

 

Germany

 

 

29,181

 

 

 

31,628

 

 

 

55,738

 

 

 

55,241

 

South Korea

 

 

24,082

 

 

 

27,670

 

 

 

47,866

 

 

 

55,854

 

Czech Republic

 

 

23,692

 

 

 

20,106

 

 

 

44,676

 

 

 

39,690

 

Mexico

 

 

17,760

 

 

 

11,823

 

 

 

33,432

 

 

 

21,838

 

Slovakia

 

 

14,571

 

 

 

14,722

 

 

 

28,293

 

 

 

27,900

 

Romania

 

 

14,566

 

 

 

13,008

 

 

 

27,523

 

 

 

27,230

 

Japan

 

 

11,679

 

 

 

14,737

 

 

 

23,778

 

 

 

27,192

 

United Kingdom

 

 

9,775

 

 

 

10,482

 

 

 

19,151

 

 

 

21,806

 

Other

 

 

48,439

 

 

 

50,939

 

 

 

93,281

 

 

 

94,450

 

Total Non-U.S.

 

 

248,345

 

 

 

248,324

 

 

 

477,273

 

 

 

478,886

 

Total Company

 

$

375,090

 

 

$

375,683

 

 

$

728,944

 

 

$

731,698

 

Property and equipment, net, for each of the geographic areas in which the Company operates as of June 30, 2025 and December 31, 2024 is as follows:

 

 

June 30, 2025

 

 

December 31, 2024

 

Property and equipment, net

 

 

 

 

 

 

Germany

 

$

49,688

 

 

$

42,457

 

Mexico

 

 

49,654

 

 

 

47,814

 

China

 

 

44,499

 

 

 

44,767

 

United States

 

 

38,847

 

 

 

42,928

 

North Macedonia

 

 

28,130

 

 

 

25,374

 

Vietnam

 

 

19,665

 

 

 

20,920

 

Czech Republic

 

 

9,916

 

 

 

9,440

 

Hungary

 

 

8,747

 

 

 

7,994

 

Ukraine

 

 

4,799

 

 

 

5,174

 

Other

 

 

8,474

 

 

 

6,102

 

Total

 

$

262,419

 

 

$

252,970